| |||||||||
|
Supplement to: Ross DB. The FDA and the Case of Ketek. N Engl J Med 2007;356(16):1601-4.
David Ross is a clinical assistant professor at George Washington University School of Medicine and Health Sciences, Washington, D.C. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. |
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |